Market Overview

Valeant Pharmaceuticals Rallying On Job Cuts (VRX)


Valeant Pharmaceuticals International (NYSE: VRX) is rallying more than 3% this morning.

This morning, Valeant Pharmaceuticals and Biovail (NYSE: BVF) announced it would be cutting more than 25% of the combined workforce between the two companies.

In June, Biovail announced it would be purchasing Valeant Pharmaceuticals.

Shares of VRX are gaining $2.17 to trade at $62.15.

Posted-In: Earnings News M&A


Related Articles (BVF + VRX)

Around the Web, We're Loving...

Get Benzinga's Newsletters

Our Experts vs. S&P 500Powered by Benzinga
Marketfy Products Return S&P 500
Morning Profit Maker 42.72% 6.69%
The Option Prophet 91.14% 6.69%
SecretCaps 26.55% 6.69%
Short-Term Trend Trading 11.89% 6.69%
View the highest rated products→